ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 55 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $71,040 | -20.2% | 12,000 | 0.0% | 0.04% | -16.3% |
| Q2 2023 | $89,040 | -21.5% | 12,000 | 0.0% | 0.05% | -22.2% |
| Q1 2023 | $113,400 | -11.3% | 12,000 | 0.0% | 0.06% | -13.7% |
| Q4 2022 | $127,800 | +43.6% | 12,000 | 0.0% | 0.07% | +28.1% |
| Q3 2022 | $89,000 | +53.4% | 12,000 | 0.0% | 0.06% | +62.9% |
| Q2 2022 | $58,000 | – | 12,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corton Capital Inc. | 13,966 | $103,000 | 0.13% |
| Delphia (USA) Inc. | 14,226 | $105,000 | 0.12% |
| Sentinus, LLC | 22,500 | $166,000 | 0.10% |
| Intrepid Financial Planning Group LLC | 20,000 | $148,000 | 0.08% |
| PERRITT CAPITAL MANAGEMENT INC | 12,000 | $89,000 | 0.06% |
| J. Goldman & Co LP | 148,738 | $1,098,000 | 0.05% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 88,966 | $657,000 | 0.02% |
| EMFO, LLC | 1,666 | $12,000 | 0.01% |
| Virtu Financial LLC | 12,590 | $93,000 | 0.01% |
| Jump Financial, LLC | 23,400 | $173,000 | 0.01% |